Can SARS-CoV-2 infection trigger rheumatoid arthritis? A case report

被引：8

作者：

Bouzid, Sirine ^{[1
,2
]}

Ben Abdelghani, Kawther ^{[1
,2
]}

Miledi, Saoussen ^{[1
,2
]}

Fazaa, Alia ^{[1
,2
]}

Laatar, Ahmed ^{[1
,2
]}

机构：

[1] Mongi Slim Hosp, Dept Rheumatol, Tunis, Tunisia

[2] Tunis El Manar Univ, Fac Med Tunis, Tunis, Tunisia

来源：

CLINICAL CASE REPORTS | 2022年 / 10卷 / 04期

关键词：

autoimmune diseases; case report; COVID-19; rheumatoid arthritis;

D O I：

10.1002/ccr3.5748

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Inflammatory arthritis has been reported after SARS-COV-2 infection. We present a case of a 38-year-old female patient who developed polyarthralgia 1 month after SARS-COV-2 infection. Musculoskeletal examination was significant for synovitis of hands and wrists. Antinuclear antibody (ANA), rheumatoid factor (RF), and anti-cyclic citrullinated peptide (CCP) antibodies were positive. Magnetic resonance imaging of the hands showed synovitis of the metacarpophalangeal joints and proximal interphalangeal joints of the hands, wrist joints, and tendinitis with tenosynovitis. The patient was diagnosed with seropositive nonerosive rheumatoid arthritis (RA) and initiated on therapy using nonsteroidal anti-inflammatory agents and disease-modifying anti-rheumatic drug methotrexate leading to an improvement in symptoms.

引用

收藏

页数：3

相关论文

共 17 条

[1] Diagnosis and Management of Rheumatoid Arthritis A Review [J].

Aletaha, Daniel ;

Smolen, Josef S. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (13) :1360-1372

[2] Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19 [J].

Anaya, Juan-Manuel ;

Monsalve, Diana M. ;

Rojas, Manuel ;

Rodriguez, Yhojan ;

Montoya-Garcia, Norma ;

Milena Mancera-Navarro, Laura ;

Maria Villadiego-Santana, Ana ;

Rodriguez-Leguizamon, Giovanni ;

Acosta-Ampudia, Yeny ;

Ramirez-Santana, Carolina .

JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2021, 4

[3] Risk factors for development of systemic lupus erythematosus: Allergies, infections, and family history [J].

Cooper, GS ;

Dooley, MA ;

Treadwell, EL ;

Clair, EWS ;

Gilkeson, GS .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2002, 55 (10) :982-989

[4] Onset of rheumatoid arthritis after COVID-19: coincidence or connected? [J].

Derksen, Veerle F. A. M. ;

Kissel, Theresa ;

Lamers-Karnebeek, Femke B. G. ;

van der Bijl, Arie E. ;

Venhuizen, Annemarie C. ;

Huizinga, Tom W. J. ;

Toes, Rene E. M. ;

Roukens, Anna H. E. ;

van der Woude, Diane .

ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (08) :1096-1098

[5]

Dotan Arad, 2021, Harefuah, V160, P62

[6] Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review [J].

Edgar Gracia-Ramos, Abraham ;

Angel Saavedra-Salinas, Miguel .

RHEUMATOLOGY INTERNATIONAL, 2021, 41 (04) :799-809

[7] High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review High levels of anti-SSA/Ro antibodies in COVID-19 [J].

Fujii, Hiroyuki ;

Tsuji, Taisuke ;

Yuba, Tatsuya ;

Tanaka, Shunya ;

Suga, Yoshifumi ;

Matsuyama, Aosa ;

Omura, Ayaka ;

Shiotsu, Shinsuke ;

Takumi, Chieko ;

Ono, Seiko ;

Horiguchi, Masahito ;

Hiraoka, Noriya .

CLINICAL RHEUMATOLOGY, 2020, 39 (11) :3171-3175

[8] Post-COVID-19 arthritis: a case report and literature review [J].

Gasparotto, M. ;

Framba, V. ;

Piovella, C. ;

Doria, A. ;

Iaccarino, Luca .

CLINICAL RHEUMATOLOGY, 2021, 40 (08) :3357-3362

[9] High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia [J].

Gazzaruso, Carmine ;

Carlo Stella, Nicoletta ;

Mariani, Giuseppe ;

Nai, Carlo ;

Coppola, Adriana ;

Naldani, Daniela ;

Gallotti, Pietro .

CLINICAL RHEUMATOLOGY, 2020, 39 (07) :2095-2097

[10] Respiratory viral infections and the risk of rheumatoid arthritis [J].

Joo, Young Bin ;

Lim, Youn-Hee ;

Kim, Ki-Jo ;

Park, Kyung-Su ;

Park, Yune-Jung .

ARTHRITIS RESEARCH & THERAPY, 2019, 21 (01)